Cargando…
Anti-idiotype antibodies in cancer treatment
Autores principales: | Gomez, Daniel E., Vázquez, Ana M., Alonso, Daniel F., Macías, Amparo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581801/ https://www.ncbi.nlm.nih.gov/pubmed/23447805 http://dx.doi.org/10.3389/fonc.2013.00037 |
Ejemplares similares
-
Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides – preclinical and clinical data
por: Vázquez, Ana M., et al.
Publicado: (2012) -
Anti-idiotype antibodies in cancer treatment: the pharmaceutical industry perspective
por: Gómez, Roberto E., et al.
Publicado: (2012) -
Anti-ganglioside antibodies induced in chickens by an alum-adsorbed anti-idiotype antibody targeting NeuGcGM3
por: Guthmann, Marcelo D., et al.
Publicado: (2013) -
Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancer
por: Segatori, Valeria I., et al.
Publicado: (2012) -
Anti-idiotypic antibodies as cancer vaccines: achievements and future improvements
por: Ladjemi, Maha Z.
Publicado: (2012)